← All drugs Report issue

as-602868

Small moleculeexperimental

Clinical trial activity

0 trials · 0 clinical orgs · 0 marketing orgs

Phase 1

0

Phase 2

0

Phase 3

0

Phase 4

0

Mechanism of action

Inhibitor of nuclear factor kappa B kinase beta subunitINHIBITOR
IKBKB inhibitor
- Inhibitor of nuclear factor kappa-B kinase subunit beta (IKBKB) ↗
Tyrosine-protein kinase receptor FLT3INHIBITOR
FLT3 inhibitor
- Receptor-type tyrosine-protein kinase FLT3 (FLT3) ↗

Chemistry & pharmacology

Loading structure…

SMILES

COc1cccc2nc(-c3cccs3)nc(NN3C(=O)C=C(C)C3=O)c12

Mol. weight: 366.4 g/mol
Lipinski Ro5: Pass
Rule of 3: No
Chirality: Achiral Molecule
Inorganic: No
Polymer: No

Oral

No

Parenteral

No

Topical

No

Sources

ChEMBLCHEMBL129857 ↗

Also known as

as-602868
as-602868
spc-839
spc-839